Brief: Spago Nanomedical Proposes Rights Issue Of Units Of About SEK 30.6 Mln

Spago Nanomedical AB (publ)

05/10/2023 07:09

Oct 5 (Reuters) - Spago Nanomedical AB (publ)
 SPAGO.ST :
    * SPAGO NANOMEDICAL PROPOSES A FULLY GUARANTEED RIGHTS ISSUE
OF
UNITS OF APPROXIMATELY SEK 30.6 MILLION TO ADVANCE TUMORAD
    * LARGEST SHAREHOLDER, PETER LINDELL THROUGH CIDRO
FÖRVALTNING,
PARTICIPATES WITH SEK 10 MILLION IN GUARANTEE COMMITMENT
    * SUBSCRIPTION PRICE IN RIGHTS ISSUE IS SET AT SEK 0.24 PER
UNIT,
EQUIVALENT TO SEK 0.24 PER NEW SHARE
    * SUBSCRIPTION PERIOD RUNS FROM NOVEMBER 9, 2023, UP TO AND
INCLUDING NOVEMBER 23, 2023.
    * PROCEEDS TO BE USED TO COVER INITIAL WORKING CAPITAL
REQUIREMENT
FOR CONTINUED DEVELOPMENT OF TUMORAD
    * EACH EXISTING SHARE IN COMPANY AS OF RECORD DATE ON
NOVEMBER 7,
2023, ENTITLES HOLDER TO SEVEN (7) UNIT RIGHTS
    * FIVE (5) UNIT RIGHTS ENTITLE HOLDER TO SUBSCRIBE FOR ONE
(1)
UNIT.
    * EACH UNIT CONSISTS OF ONE (1) SHARE AND ONE (1) WARRANT OF
SERIES TO12.
    * TRANSACTION COSTS FOR RIGHTS ISSUE ARE ESTIMATED TO AMOUNT
TO
APPROXIMATELY SEK 4.9 MILLION

Source text for Eikon:  ID:nMFN3lZMM2 
Further company coverage:  SPAGO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))